Depixus in the news

We regularly participate in the world’s leading conferences on tools and technologies for biomolecular analysis and therapeutics. Look out for our presentations and come and say hello to learn more about MAGNA™ and its transformative potential for life sciences research and drug development.

Depixus to showcase unique single molecule technology solving the hit-to-lead challenge in RNA-targeted drug discovery at upcoming Discovery on Target Conference

PARIS–(BUSINESS WIRE)–Dr Gordon Hamilton, President & CEO of Depixus SAS, will be showcasing the company’s pioneering approach to transform RNA…

Read More